EU antitrust - Article 102 TFEU

Dominance

Article 102 TFEU prohibits undertakings that (individually or collectively) hold a dominant position within the EU or a substantial part of it from abusing their dominance (without objective justification) insofar as it may affect trade between Member States. This provision is mirrored in the national competition laws of EU Member States and which can apply even where an effect on inter-state trade is not established.

The distinction between abusive and legitimate (permissible) conduct by a dominant undertaking may be hard to discern—for example, a price reduction resulting from production efficiencies/economies as opposed to a ‘predatory’ price cut. Dominant undertakings are permitted (and indeed expected) to compete aggressively on a given market but such behaviour should reflect competition ‘on the merits’.

The application of Article 102 TFEU has three constituent elements:

•
establishing ‘dominance’
•
confirming prima facie restrictive unilateral conduct, and
•
assessing whether there is ‘objective justification’ for any such conduct—if not (and only then) can the conduct in question legally be construed as an ‘abuse’

For further information, see Practice Notes: Article 102 TFEU—the prohibition on abuse of dominance and Dominant

To view the latest version of this document and thousands of others like it, sign-in with LexisNexis or register for a free trial.

TAKE A FREE TRIAL

Latest EU Law News

Commission publishes FAQ on health technology assessment regulation implementation

The European Commission has published guidance clarifying the implementation of Regulation (EU) 2021/2282 on health technology assessment (HTA). The FAQ document outlines the conditions under which products are subject to JCA, including those with new active substances for cancer treatment and advanced therapy medicinal products, starting from 13 January 2025. The regulation follows a stepwise approach, expanding to orphan medicinal products in 2028 and all relevant products by 2030. Applications must comply with Article 8(3) of Directive 2001/83/EC, excluding generics, biosimilars and other simplified procedures.

Council of the EU adopts position on CAP simplification package

The Council of the EU has adopted its position on the Commission’s ‘Omnibus III’ legislative package, aimed at simplifying the Common Agricultural Policy (CAP) to enhance the competitiveness of European agriculture. The package amends the key CAP regulations to reduce administrative burdens, improve support for small and organic farms, and streamline compliance procedures. The Council endorsed measures expected to generate annual savings of up to €1.6bn for farmers and over €200m for national administrations, while also introducing greater flexibility for member states, enhanced risk management tools, and increased advance payments for farmers affected by crises. Negotiations with the European Parliament will follow once it adopts its position, with the initiative forming part of a broader EU strategy to reduce regulatory burdens and improve operational conditions across sectors.

MedTech Europe position paper calls for CSDDD and CSRD simplification

MedTech Europe has published a position paper on the proposed revisions to the Corporate Sustainability Due Diligence Directive (CSDDD) and the Corporate Sustainability Reporting Directive (CSRD). MedTech supports confining due diligence obligations to Tier 1 suppliers and welcomes the elimination of the harmonised EU civil liability regime. Additionally, MedTech advocates for the extension of monitoring periods from 12 months to five years, capping penalties to 5% of turnover, and maintaining limited assurance requirements under the CSRD. Overall, the paper seeks to reduce administrative burdens while ensuring that sustainability reporting frameworks remain effective.

EU Law weekly highlights—4 September 2025

This week's edition of EU Law weekly highlights includes analysis of the International Court of Justice’s first advisory opinion on climate change. In addition this week, leading AI companies have been presented with the preliminary findings of expert reports that will inform a voluntary EU code of practice on labelling AI-generated content under the EU AI Act, the European Commission launched consultations on an EU Electrification Action Plan, an EU Heating and Cooling Strategy, and implementing rules supplementing the EU Carbon Border Adjustment Mechanism Regulation, and the Commission's Directorate-General for Climate Action published three reports examining the design of an EU-wide purchasing programme for permanent carbon dioxide removals. Finally, MedTech Europe has published a position paper proposing reforms to simplify EU digital legislation for medical devices and the Commission launched a new voluntary Code of Conduct for Online Ratings and Reviews for Tourism Accommodation.